Skip to main content

Advertisement

SpringerLink
Log in

A Retrospective Search for Predictors of Clinical Response to Selective Granulocyte and Monocyte Apheresis in Patients With Ulcerative Colitis

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Recently, selective granulocytapheresis (Adacolumn) has appeared as a new treatment for patients with inflammatory bowel disease. This study sought to determine predictors of response to this new nonpharmacologic mode of therapy by retrospectively evaluating 28 patients who received granulocytapheresis after experiencing active ulcerative colitis (UC). Between April 2000 and March 2004, 28 consecutive patients received granulocytapheresis for active UC with the Adacolumn, which is filled with cellulose acetate beads as the column leukocytapheresis carriers; the carriers adsorb granulocytes, monocytes/macrophages, and a small fraction of lymphocytes (FcγR and complement receptors bearing leukocytes). Each patient could receive up to 10 Adacolumn sessions, at 2 sessions per week. In 2004, clinical response was retrospectively evaluated. Seven days after the last Adacolumn session, 20 of 28 patients had remission (colitis activity index [CAI] ≤4) including all 8 patients who had their first UC episode. The mean duration of UC in the 8 first episode cases was 3.4 months compared with 40.2 months for all 28 patients and 65.4 months for the 8 nonresponders. The response to Adacolumn was independent of basal CAI. The 8 nonresponders were given conventional medication (CM) or cyclosporine (CsA) if the former failed. Two responded to CM, 3 to CsA, and 3 underwent colectomy. First UC episode and short disease duration appear good predictors of response to granulocytapheresis. Selective granulocytapheresis might be an effective first-line treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. McCarthy DA, Rampton DS, Liu Y-C (1991) Peripheral blood neutrophils in inflammatory bowel disease. Morphological evidence of in vivo activation in active disease. Clin Exp Immunol 86:489–493

    Article  PubMed  CAS  Google Scholar 

  2. Grisham MB, Yamada T (1992) Neutrophils, nitrogen oxides and inflammatory bowel disease, neuro-immuno-physiology of the gastrointestinal mucosa. Ann NY Acad Sci 664:103–115

    PubMed  CAS  Google Scholar 

  3. Allison MC, Dhillon AP, Lewis WG, Pounder RE (eds) (1998) Inflammatory Bowel Disease. Mosby, London, pp 15–95

    Google Scholar 

  4. Tibble JA, Sigthorsson G, Bridger D (2000) Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15–22

    Article  PubMed  CAS  Google Scholar 

  5. Bjarnason I, Macpherson A, Menzies IS (1994) Intestinal permeability: The basics. In: Sutherland LR, Collins SM, Martin F, McLeod RS, Targan SR, Wallace JL, Williams CN (eds) Inflammatory bowel disease. Basic research, clinical implications and trends in therapy. Kluwer Academic Press, Dordrech, pp 53–70

    Google Scholar 

  6. Bjarnason I, Macpherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108:1566–1581

    Article  PubMed  CAS  Google Scholar 

  7. Cassatella MA (1995) The production of cytokines by polymorphonuclear neutrophils. Immunol Today 16:21–26

    Article  PubMed  CAS  Google Scholar 

  8. Nikolaus S, Bauditz J, Gionchetti P (1998) Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation. Gut 142:470–476

    Article  Google Scholar 

  9. Hanai H, Watanabe F, Takeuchi K, Saniabadi A (2003) Leucocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective uncontrolled pilot study. Clin Gastroenterol Hepatol 1:28–35

    Article  PubMed  Google Scholar 

  10. Brannigan AE, O’Connell PR, Hurley H (2000) Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock 13:361–366

    PubMed  CAS  Google Scholar 

  11. Roseth AG, Schmidt PN, Fagerhol MK (1999) Correlation between faecal excretion of Indium-111-labelled granulocytes and calprotectin, a granulocyte marker. Scand J Gastroenterol 34:50–54

    Article  PubMed  CAS  Google Scholar 

  12. Lee A, Whyte M, Haslett C (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 283–288

  13. Meagher LC, Cousin JM, Seckl JR, Haslett C (1996) Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156:4422–4428

    PubMed  CAS  Google Scholar 

  14. Ohara M, Saniabadi AR, Hirata I, Kasukawa R (1997) Granulocytapheresis in the treatment of patients with rheumatoid arthritis. Artif Organs 21:989–994

    Article  PubMed  CAS  Google Scholar 

  15. Saniabadi AR, Hanai H, Lofberg R (2003) Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 7:48–59

    Article  PubMed  Google Scholar 

  16. Saniabadi AR, Hanai H, Suzuki Y, Lofberg R (2005) Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy? J Clin Apher 20:171–184

    Article  PubMed  Google Scholar 

  17. Hiraishi K, Takeda Y, Shiobara N (2003) Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial 7:334–340

    Article  PubMed  Google Scholar 

  18. D’Arrigo C, Candal-Couto JJ, Greer M (1993) Human neutrophil Fc receptor-mediated adhesion under flow: a hallow fiber model of intravascular arrest. Clin Exp Immunol 100:173–179

    Article  Google Scholar 

  19. Rachmilewitz D, on behalf of an international study group (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 298:82–86

    Article  CAS  Google Scholar 

  20. Hanai H, Watanabe F, Saniabadi A (2002) Therapeutic efficacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci 47:2349–2353

    Article  PubMed  Google Scholar 

  21. Kanke K, Nakano M, Hiraishi H, Terano A (2004) Evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig Liv Dis 36:512–518

    Article  Google Scholar 

  22. Suzuki Y, Yoshimura N, Saniabadi AR (2004) Selective neutrophil and monocyte adsorptive apheresis as a first line treatment for steroid naïve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 49:565–571

    Article  PubMed  CAS  Google Scholar 

  23. Cohen RD (2005) Treating ulcerative colitis without medications—“Look Mom, No Drugs!” Gastroenterology 128:235–236

    Article  PubMed  Google Scholar 

  24. Agius LM (2004) A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. J Theor Biol 227:219–228

    Article  PubMed  Google Scholar 

  25. D’Haens G, Lemmens L, Geboes K (2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 120:1323–1329

    Article  PubMed  CAS  Google Scholar 

  26. Naganuma M, Funakoshi S, Sakuraba A (2004) Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis. Inflamm Bowel Dis 10:251–257

    Article  PubMed  Google Scholar 

  27. Yamamoto T, Umegae S, Kitagawa T (2004) Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study. Aliment Pharmacol Ther 20:783–792

    Article  PubMed  CAS  Google Scholar 

  28. Tomomasa T, Kobayashi A, Kaneko H (2003) Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis. Dig Dis Sci 48:750–754

    Article  PubMed  Google Scholar 

  29. Premchand P, Takeuchi K, Bjarnason I (2004) Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis. Eur J Gastroenterol Hepatol 16:943–945

    Article  PubMed  Google Scholar 

  30. Hanai H, Watanabe F, Yamada M (2004) Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis. Digestion 70:36–44

    Article  PubMed  CAS  Google Scholar 

  31. Domenech E, Hinojosa J, Esteve-Comas M (2002) Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther 20:1347–1352

    Article  Google Scholar 

  32. Kashiwagi N, Saniabadi A, Shimoyama T (2002) Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 47:1334–1341

    Article  PubMed  CAS  Google Scholar 

  33. Tabuchi T, Saniabadi AR (1999) Granulocyte apheresis as a possible new approach in cancer therapy: a pilot study involving two cases. Cancer Detect Preven 23:417–421

    Article  CAS  Google Scholar 

  34. Bitton A, Peppercorn MA, Antonioli DA (2001) Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 120:13–20

    Article  PubMed  CAS  Google Scholar 

  35. Irving PM, Rampton DS (2004) Leucocytapheresis for ulcerative colitis (commentary). Dig Liver Dis 36:799–802

    Article  PubMed  CAS  Google Scholar 

  36. Biswas P, Mantelli B, Hasson H (2003) In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders. Clin Immunol 109:355–358

    Article  PubMed  CAS  Google Scholar 

  37. Hogg N, Berlin C (1995) Structure and function of adhesion receptors in leucocyte trafficking. Immunol Today 16:327–330

    Article  PubMed  CAS  Google Scholar 

  38. Rottman JB, Smith TL, Ganley KG (2001) Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Lab Invest 81:335–347

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Sakura Hospital, Toho University, Chiba University School of Medicine, Tokyo, Japan

    Yasuo Suzuki, Katsuyuki Fukuda & Koji Shirai

  2. Department of Internal Medicine, Social Insurance Chuo General Hospital, Chiba University School of Medicine, Tokyo, Japan

    Naoki Yoshimura & Yasushi Saito

  3. Japan Immunoresearch Laboratories, Takasaki, Japan

    Abbi R. Saniabadi

  4. Sakura Hospital, Faculty of Medicine, Toho University, 564-1 Shimoshizu, Sakura City, Chiba, 285-874, Japan

    Yasuo Suzuki

Authors
  1. Yasuo Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoki Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katsuyuki Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Koji Shirai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yasushi Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abbi R. Saniabadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuo Suzuki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suzuki, Y., Yoshimura, N., Fukuda, K. et al. A Retrospective Search for Predictors of Clinical Response to Selective Granulocyte and Monocyte Apheresis in Patients With Ulcerative Colitis. Dig Dis Sci 51, 2031–2038 (2006). https://doi.org/10.1007/s10620-006-9199-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9199-9

Keywords

Search

Navigation